Motivation: While the use of cDNA microarrays for functional genomic analysis has become commonplace, relatively little attention has been placed on false positives, i.e. the likelihood that a change in measured radioactive or fluorescence intensity may reflect a change in gene expression when, in fact, there is none. Since cDNA arrays are being increasingly used to rapidly distinguish biomarkers for disease detection and subsequent assay development (Wellman et al., Blood, 96, 398-404, 2000), the impact of false positives can be significant. For the use of this technology, it is necessary to develop quantitative criteria for reduction of false positives with radioactivelylabeled cDNA arrays. Results: We used a single source of RNA (HuT78 T lymphoma cells) to eliminate sample variation and quantitatively examined intensity ratios using radioactively labeled cDNA microarrays. Variation in intensity ratios was reduced by processing microarrays in side-by-side (parallel mode) rather than by using the same microarray for two hybridizations (sequential mode). Based on statistical independence, calculation of the expected number of false positives as a function of threshold showed that a detection limit of | log 2 R| > 0.65 with agreement from three replicates could be used to identify up-or down-modulated genes. Using this quantitative criteria, gene expression differences between two related T lymphoma cell lines, HuT78 and H9, were identified. The relevance of these findings to the known functional differences between these cell types is discussed.
INTRODUCTION
Since the introduction of cDNA arrays (Schena et al., 1995) , there has been rapid growth in the use of this technology for the determination of differential gene expression profiles (for review, Marshall and Hodgson, * To whom correspondence should be addressed.
1998; Khan et al., 1999) . With this approach, gene expression in a cell population can be quantified by hybridization of a labeled target (we use the nomenclature of a 'probe' as the tethered nucleic acid with known sequence, whereas a 'target' is the free nucleic acid sample whose identity/abundance is being detected), derived from isolated RNA, to oligonucleotides or cDNA molecules patterned on a substrate. The measured signal intensity of bound target linearly corresponds to the abundance of transcript in the source RNA, and when measured relative to a standard, can be used to reflect modulation of gene expression (Hedge et al., 2000) . cDNA arrays have been used to identify differences in gene expression associated with toxicant exposure (Amundson et al., 1998; Zhao et al., 2000) , classification of cancer (Alon et al., 1999; Wellman et al., 2000) , viral infection of host cells (Geiss et al., 2000) , differentiation in model cell types (Dietz et al., 2000; Popovici et al., 2000) , and phenotypic distinctions between cell types (Rhee et al., 1999) .
The use of microarray technology has been typically restricted to a small number of research efforts due to the need for expensive fabrication systems. Filter-based arrays that use radioactive labeling are extremely sensitive (Bertucci et al., 1999a) and appear to provide a lower cost means for access to this powerful technology. Although the ability to conduct parallel analysis of hundreds to thousands of genes represents a major breakthrough, a concern has emerged with regard to the probability of false positives, i.e. the likelihood that a change in measured radioactive or fluorescence intensity may reflect a change in gene expression when, in fact, there is none (Duan et al., 1999; Eckmann et al., 2000) . Since cDNA arrays are being increasingly used to rapidly distinguish biomarkers for disease detection and subsequent assay development (Wellman et al., 2000) , the impact of false positives can be significant.
The aims of our study were two-fold: (1) to explore the question of false positives and develop quantitative criteria for reduction of false positives with radioactively-labeled cDNA arrays; and (2) to identify robust differences in model immune cell lines that may underlie functional, phenotypic differences. To achieve these goals, we probed 33 P-labeled cDNA generated from HuT78 human T lymphoma cells and the related 'daughter' cell line H9 with commercially available microarrays. Our data reveal that false positives are common to microarray analysis, indicating the necessity of replicates to minimize false positives. In addition, we identify differentially expressed genes in these immune cell lines using quantitative criteria and discuss the implications of these findings relative to known differences in cellular function.
SYSTEMS AND METHODS

Cell culture
HuT78 (TIB-161), H9 (HTB-176), and RH9 (CRL-12043) cell lines were purchased from the American Type Culture Collection (Manassas, Virginia) and cultured in RPMI 1640 media supplemented with 10% fetal bovine serum (Life Technologies Inc., Gaithersburg, MD). To reduce biologic variability, cultures were grown in triplicate, and the resulting RNA from each culture set was pooled.
cDNA microarrays
Commercially-available cDNA microarrays GeneFilters R (GF-200, Research Genetics, Huntsville, AL) were used throughout all of the experiments described, and standard procedures recommended by the manufacturer were followed.
RNA isolation
Approximately 1.9 × 10 6 cells were harvested and frozen at −80 • C until used. The pellets were thawed on ice and disrupted in 2 ml TRIzol R reagent (Life Technologies). The samples were incubated at room temperature for 15 min then 0.4 ml chloroform was added. Samples were mixed then centrifuged at 2000 g. The aqueous phase was transferred to a 30 ml Kimble HS glass tube and 1 ml isopropyl alcohol was added to precipitate the RNA. After 30 min at room temperature, the samples were spun in a Sorvall centrifuge at 12 000 g at 4 • C for 30 min. The supernatant was discarded and the RNA pellet was rinsed with 3 ml cold 75% ethanol. The sample was centrifuged again for 15 min at 12 000 g, the supernatant was discarded and the pellet was air-dried for approximately 20 min. The pellet was re-suspended in 0.5 ml nuclease-free water (Ambion Inc., Austin, TX) then treated with DNAse (Stratagene Inc., San Diego, CA). Following the DNAse treatment, the RNA was recovered by ethanol precipitation. RNA quality was verified by spectrophotometric analysis and stored at −80 • C until use.
Preparation of 33 P-labeled target
Microarrays were washed in boiling 0.5% SDS for 5 min then pre-hybridized for 2 h at 42 • C in a roller tube containing 5.0 ml MicroHyb (Research Genetics) hybridization solution plus 5.0 µg denatured human Cot-1 DNA (Life Technologies) and 5.0 µg Poly dA (Research Genetics). RNA was diluted to 1 µg/µl in nuclease-free water. To 7 µl of nuclease free water, 1.0 µl of diluted RNA and 2.0 µl of 1 µg/µl oligo dT (Research Genetics) were added and the mixture was heated at 70 • C for 10 min, then cooled to 4 • C for 2 min. A mixture of 6.0 µl 5× First Strand buffer (Life Technologies), 1.0 µl of 0.1 M DTT, and 1.5 µl of 20 mM dNTP (dCTP, dGTP, dTTP; Amersham Pharmacia Biotech, Piscataway, NJ) was added to the primed RNA. Finally, 1.5 µl (200u/µl) of SuperScript II reverse transcriptase (Life Technologies) and 10 µl of Redivue 33 P-dATP (at a concentration of 10 mCi/ml with a specific activity of 3000 Ci/mmol; Amersham Pharmacia Biotech) were added. The sample was mixed thoroughly and centrifuged briefly before incubating at 37 • C for 90 min. All heating and cooling of the sample was done in a 0.5 ml thin-walled PCR tube using programmable thermal cycler (MJ Research Inc., Watertown, MA). Radiolabeled target was purified using a Bio-Spin chromatography column (Bio-Rad, Hercules, CA) according to the manufacturers protocol and incorporating Research Genetics-suggested modifications.
Hybridization and exposure
Purified target was denatured for 3 min in a boiling water bath, then pipetted into the roller tube containing the microarray and the prehybridization solution. Microarrays were hybridized overnight at 42 • C in a hybridization roller oven (Hybaid Inc., Franklin, MA). Washes were done twice at 50 • C in 2× SSC, 1% SDS for 20 min and once at 55 • C 2 in 0.5× SSC, 1% SDS for 15 min in the hybridization oven roller tube that was used throughout the experiment. Microarrays were wrapped in plastic and placed in a cassette with a phosphor-imaging screen. Exposure time was 6 h. Images were acquired using a Cyclone phosphorimager (Packard Instruments, Meriden, CT) and Pathways TM analysis software (Research Genetics). Microarrays were stripped by placing them in boiling 0.5 % SDS then allowing them to cool with agitation for 1 h.
Analysis and statistics
Data analyses were performed using Excel 97 (Microsoft, Redmond, WA) and results were graphed using Sigmaplot for Windows version 5 (SPSS Inc., Richmond, CA). Intensity data from each microarray were normalized to the median intensity before comparison. In deriving probabilities from the comparison of control HuT78 data, we considered only intensities greater than three times the background (determined as the lowest measured spot intensity). This limited quantitative analysis to 2578-2739 of the 5180 spots on the microarrays, a similar range of spots was observed for the other cell lines. For all comparisons, we only considered spots where all of the replicates have intensities greater than three times the background. For the sake of simplicity for probability calculations, the number of genes was set to 2500, a conservative estimate. Intensity ratios were log base 2 transformed so that a ratio of 0.5 exhibited the same deflection from unity as a ratio of 2. For calculation of correlation, since intensity ratios are not expected to follow a normal distribution, the Spearman correlation coefficient was calculated using a statistical analysis 'add-in' for Excel (Analyse-It Software Ltd, Leeds, England), with P < 0.05 considered significant. Where appropriate, data are given as mean ± SEM and statistical significance determined using Student's t-test with P < 0.05 considered significant.
RESULTS
Quantification of false positives
To determine the likelihood of false positives, two trials with four microarrays were conducted using target prepared from the same source RNA, which was derived from cultured HuT78 cells. Two different ways of conducting radiolabeled cDNA microarray experiments have been suggested. Given the expense of cDNA microarrays, manufacturers advise 'sequential' use: i.e. after control target hybridization and quantification, the same microarray is stripped for re-use with the treatment target. Alternatively, control and treatment measurements can be performed in 'parallel' on two separate microarrays. With the use of the same source RNA, the utility of each of these approaches were compared. Thus, four microarrays were probed simultaneously (parallel) and then re-probed (serial mode).
Ideally, a measurement system should show no difference between exposures using the same target. In other words, after normalization, the calculated log ratios of each pair of spots should equal zero. Using the same target, side-by-side hybridization of two separate microarrays yielded a smaller variation than sequential hybridization (Figure 1 ). Manufacturers of microarrays typically claim to be able to distinguish reliably twofold changes. Therefore, for initial analysis of the array data, false positives were defined as when the ratio, R, was either less than 0.5 or greater than 2, i.e. | log 2 R| > 1. In the experiment shown in Figure 1 , the parallel measurements showed a probability of false positives of 0.007; however, sequential determinations resulted in an apparent probability of false positives of 0.054. Similar trends were observed in three other data comparisons. These data indicated that experimental variability could be reduced by preparation of radiolabeled target and hybridization in a parallel rather than in a sequential manner. Summary statistics were derived for the four arrays processed in parallel, yielding six comparisons. Results showed that the vast majority of the ratios, 97.9 ± 0.4% (mean ± SEM, n = 6) were below 2 and greater than 0.5, i.e. | log 2 R| 1. Although only 2.1% of the ratios were above threshold, i.e. | log 2 R| > 1, this corresponded to, on average, 52 genes. For each pair of spots, the standard deviation of the log-transformed ratios was calculated. Figure 2 , which shows a histogram of the standard deviations, indicates that ratios can vary from unity by, on average, 0.23 log 2 units. More simply, under conditions of identical labeled target, one can expect the parallel method to yield intensity ratios spanning ± a standard deviation or ranging from 0.83 to 1.17.
A possible source of false positives could be fabrication defects, i.e. the density of oligonucleotide molecules deposited at a particular spot for one microarray may differ substantially from that of the other microarray used in the comparison. If this was the case, then one would expect a statistically significant correlation, r , between the intensity ratios generated between trials. Analysis of corresponding ratios derived from two trials using the same pair of microarrays yielded a small yet statistically significant (P < 0.05) correlation, r = 0.18; similar results were observed for the other pair of microarrays. These data suggested that 3.2% of the variance in ratios of one trial could be attributed to the ratios of the first trial. Nevertheless, the number of reproducible pairs of spots that showed | log 2 R| > 1 constituted only 2% of all of the false positives. Therefore, pairs of spots that yield false positives could not be eliminated by prior evaluation of the microarrays. As expected, no statistically significant correlation was observed between separate pairs of microarrays across the two trials, consistent with each of the measurements constituting an independent event.
Clearly, the determination of a factor of two as a threshold for false positives is arbitrary. Using the HuT78 control data set, we next examined the relationship between the probability of a false positive and other threshold levels. Assume that we want the number of false positives, N FP , to be <1. Note that:
where N G is number of genes and, for example, p FP is probability of a spot on the array yielding a false positive where log 2 R exceeds a threshold level. Assuming independent events, then the probability of a measured ratio exceeding the threshold for n replicates, p FP,n , is: Fig. 1 . Parallel handling of radiolabeled cDNA microarrays reduces variability in the intensity ratios. Comparison of log 2 transformed intensity ratios derived from control experiments processed using (a) two separate cDNA microarrays in parallel mode versus (b) the same cDNA microarray in sequential fashion. Control RNA was isolated from HuT78 cells and genes whose intensity was below three times the background intensity on any microarray were excluded from analysis. These data indicate that experimental variability can be reduced by preparation of radiolabeled target and hybridization in a parallel rather than in a sequential manner. Figure 3a and b are expected numbers of false positives for calculated N FP values as a function of threshold for n = 1, n = 2, and n = 3 replicates. By choosing a threshold of log 2 R > 0.65 for n = 3 replicates, the expected N FP falls below 1. In addition, this lower threshold does not sacrifice sensitivity, since the ratios can exhibit variation as shown in Figure 2 . Analysis of the control data sets using this criteria showed that for n = 3 replicates, two genes and one gene exhibited a log 2 transformed ratio greater than 0.65 and less then −0.65, respectively, consistent with the expected values. Fig. 2 . Variability of intensity ratios derived from radiolabeled cDNA microarrays. Histogram of the standard deviations of the log 2 transformed control intensity ratios showing that ratios can vary from unity by, on average, 0.23 log 2 units. Data were calculated from processing four cDNA microarrays in parallel using the same control labeled target derived from HuT78 RNA and genes whose intensity was below three times the background intensity on any microarray were excluded from analysis.
Shown in
This threshold of 0.65 is not a theoretical value, but instead an empirically derived value and cannot be applied to other microarray systems without experimental confirmation.
Further experiments were performed to assess additional variability that may emerge during the reverse transcription and labeling steps. From the same pool of HuT78 RNA, four samples were processed in parallel and the corresponding log 2 R values for the six comparisons were computed. The distribution of ratios was not markedly different than that derived from application of identical labeled target to the microarrays (0.57 vs 0.65). Therefore, we utilized the more conservative threshold of 0.65 for subsequent experiments to identify differentially expressed genes.
Cell line comparison
The H9 cell line is genetically identical to HuT78 based on allozyme patterns (Mann et al., 1989) , DNA fingerprints (Gilbert et al., 1990) , and karyotypic analysis (Chen, 1992) , indicating that H9 is a clonal subline derived from HuT78. Differences in gene expression were explored between cultures of HuT78 versus H9 cell lines. To reduce biologic variability, cultures were grown in triplicate, and the resulting RNA from each culture set was pooled.
Using the above quantitative criteria, relatively few reproducible differences were observed between the cell lines. As listed in Table 1 , 17 and 10 genes were upregulated and down-regulated, respectively, in HuT78 versus H9. A similar comparison was performed between Fig. 3 . Importance of replicates to the analysis of radiolabeled cDNA microarrays. Probability of false positives as a function of threshold, X , was calculated for (a) log 2 R > X and (b) log 2 R < X . The plots show the profiles of the expected number of false positives for a single iteration (n = 1), as well as multiple replicates (n = 2 and n = 3). As shown, the expected number of false positives falls below 1 at a threshold of 0.65 for n = 3 replicates. Data were calculated from processing four cDNA microarrays in parallel using the same control labeled target derived from HuT78 RNA and genes whose intensity was below three times the background intensity on any microarray were excluded from analysis.
HuT78 and RH9, a CD4 + cell line derived from HuT78 (Henderson and Qureshi, 1993; Makutonina et al., 1996) . Five ESTs were differentially expressed in a manner common to both H9 and RH9 relative to HuT78. These data suggest that in spite of the genetic similarity of these T-lymphoma cell lines, distinctions in gene expression can be identified using the cDNA microarrays, which perhaps contribute to phenotypic differences between the cell lines.
DISCUSSION
Radioactively labeled cDNA arrays offer a cost-effective approach for gene expression analysis. Due to the high degree of sensitivity imparted by the use of radioactive labeling, these cDNA arrays typically do not require a large quantity of RNA or mRNA, and therefore, may be a choice well suited for small tissue samples. While there have been many recent studies using radioactively-labeled cDNA arrays, the limitations of this methodology have not been previously explored in quantitative detail. To this end, we have conducted a study to quantify the probability of false positives inherent in this approach. Manufacturers suggest that arrays can be used in a sequential manner (i.e. re-use of the same array after stripping) and that 2-fold changes are considered 'significant'. In contrast, we demonstrated that false positives were greatly reduced by parallel handling of arrays. Moreover, even under ideal experimental conditions, a user can expect a substantial number of genes to exceed a two-fold threshold when no true differences exist. Based on our analysis, the use of replicate experiments to gain confirmation resulted in a reduction in false positives. Our observations indicated that these considerations were not largely due to manufacturing differences between cDNA arrays, since only 2% of the false positives (| log 2 R| > 1) were reproduced after array reuse. While quantitative assessments of cDNA array performance have been lacking in the published literature, our observations are consistent with work from Bertucci et al. (1999b) , using macroarrays, showing that 97-98% of the clones showed less than a two-fold difference in signal intensity. In addition, the present findings are consistent with results derived from fluorescence-based cDNA microarrays, which generate ratios based on single spots; this approach, like radiolabeled cDNA arrays, requires replicates for robust data interpretation . Thus, findings from brief studies that rely on single array comparisons must be regarded with caution.
There are several sources of variation that can emerge in gene expression analysis; these include: biologic variability, microarray production batch, laboratory or handling factors, and variability emerging during sample processing. In the present experiments, pooling RNA from multiple cultures of each cell type reduced biologic variability. Variation contributed by reverse transcription and labeling appears to be relatively minor, since we observed similar distributions of log 2 R values from identical RNA processed in parallel versus identical labeled probe. By determining the probability of false positive results, we were able to proceed with experiments that sought true positives. Using quantitative criteria established with the baseline control experiments described above, gene expression differences between HuT78 and the descendent cell line H9 were determined. Although HuT78 and H9 exhibit genetic similarity, these cell types differ in their Note. Genes and expressed sequence tags (ESTs) were identified as up-or down-modulated based on agreement of 3 independent replicates where the intensity ratio, R, of H9 gene/HuT78 gene exceeded a threshold. As described earlier, the threshold for identification was set at | log 2 R| > 0.65. The upper portion of the table lists genes/ESTs expressed at higher levels in H9 cells; the lower portion of the table gives genes/ESTs expressed at higher levels in HuT78 cells. Data are reported as the average of the log transformed ratios. ESTs were considered highly similar to a gene if the BLAST score exceeded 500 (Altschul et al., 1997) . *Denotes that a similar modulation in gene expression was observed between HuT78 and RH9 cell lines.
permissiveness for HIV infection (Bunn and Foss, 1996) . From a survey of many hematopoetic cell lines, H9 exhibited the highest viral replication rate (Popovic et al., 1984) . Given their well-known differential susceptibility to HIV infection of these two cell lines, several genes that are upregulated in H9 cells relative to HuT78 cells are noteworthy. Neutral amino acid transporters are receptors for type D retroviruses, some of which cause simian acquired immune deficiency syndrome (Rasko et al., 1999; Marin et al., 2000) . Increased expression of this gene may result in more binding sites for HIV in human cells. Pur-alpha, a DNA binding protein forms a complex with Tat, which binds in a specific manner to the HIV-1 Tat-responsive DNA element activating HIV-1 transcription (Krachmarov et al., 1996; Chepenik et al., 1998) . PLAG-1, a developmentally regulated C2H2 zinc finger protein and transcription factor has been recently identified (Voz et al., 2000) ; other C2H2 zinc finger proteins bind HIV-1 promoter regions (Suzuki et al., 1998) and are up-regulated in HTLV-1 infected T cells (Drew et al., 1997) .
In contrast, eukaryotic initiation factor 2 (EIF-2) was expressed at lower levels in H9 versus HuT78 cells. Other translation initiation factors, such as human initiation factor 2 (hIF2), interact with HIV-1 matrix and Gag in vitro resulting in inhibition of translation (Wilson et al., 1999) . The lower level of EIF-2 in H9 may derepress translation, allowing higher protein production during HIV infection. Two ESTs with high similarity to ubiquitination factor 4B and cyclophilin A are particularly noteworthy. The EST similar to ubiquitination factor 4B was expressed at lower levels in H9 versus HuT78 cells. This factor is required for efficient multi-ubiquitination of substrates destined for processing by proteasomes (Koegl et al., 1999) . In addition, HIV-1 Env glycoprotein is degraded via ubiquitination (Bultmann et al., 2000) . Thus the lower level of ubiquitination factor 4 in H9 cells may result in less Env degradation, perhaps contributing to the permissiveness of H9 cells for HIV replication. Cyclophilin A is specifically associated with HIV virions and mediates HIV-1 attachment to target cells (Saphire et al., 2000) . Interestingly, according to Yin et al. (1998) , there are narrow constraints on the level of cyclophilin A with respect to HIV infectivity, such that excessively high cyclophilin A levels can render the virion core unstable. An EST very similar to RNA helicase was expressed at a lower level in H9 versus HuT78 cells. RNA helicase A has a role in post-transcriptional regulation of HIV-1 (Li et al., 1999) and is down-regulated in HIV-1 infected Tcells (Ryo et al., 1999) , although it is presently difficult to interpret the significance of differential expression of this EST in H9 versus HuT78 cells. Likewise, there are several ESTs that have little homology to known genes, making interpretation difficult. Among these ESTs are five ( Table 1) that also show a similar relative expression profile for RH9 cells. These ESTs may eventually prove to be extremely interesting in explaining phenotypic differences between HuT78 and these subclones.
In summary, we have addressed the limitations of radiolabeled cDNA microarrays, especially with regard to false positives, and developed quantitative criteria for the identification of differentially expressed genes. Clearly, large-scale gene expression studies that do not utilize replicates, or other means to confirm gene expression findings, must be regarded with caution. We showed the genetically similar immune cell lines HuT78 and H9 differ in the expression of a relatively small set of genes and ESTs. While the expression of several of these genes/ESTs was interpreted in the context of a well-known differential permissiveness for HIV infection, further work will be required to characterize their importance to cellular function.
